Bimatoprost Solution/ Drops
Product Images NDC 62332-507

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bimatoprost (NDC 62332-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bimatoprost-bottle-2-5ml (Bimatoprost Bottle 2 5ml)

Bimatoprost-bottle-2-5ml (Bimatoprost Bottle 2 5ml)
This is a description of a prescription medication called Bimatoprost Ophthalmic, used in the eyes only. The medication contains 0.03% (0.3mg) of bimatoprost and the preservative benzalkonium chloride. The usual dosage and storage instructions are not provided. The medication is manufactured by Alembic Pharmaceuticals, Inc in India.*
FDA Label Image

Bimatoprost-bottle-5ml (Bimatoprost Bottle 5ml)

Bimatoprost-bottle-5ml (Bimatoprost Bottle 5ml)
Bimatoprost Ophthalmic Solution is a prescription medication indicated for the treatment of intraocular pressure in people with ocular hypertension or open-angle glaucoma. It is manufactured by Alembic Pharmaceuticals in Bedminster, New Jersey and contains 0.03% (0.3 mg) of bimatoprost and benzalkonium chloride NF 0.05 mg/mL as a preservative. The solution is sterile and should only be used in the eyes. It is sold in a 5mL bottle and the usual dosage should be determined by a physician or per the package insert instructions. The solution should be stored at 2°C to 25°C (36°F to 77°F).*
FDA Label Image

Bimatoprost-carton-2-5ml (Bimatoprost Carton 2 5ml)

Bimatoprost-carton-2-5ml (Bimatoprost Carton 2 5ml)
This is a product description for Bimatoprost Ophthalmic Solution, which is intended for use in the eyes only. Each mL of solution contains bimatoprost 0.03% and benzalkonium chloride NF 0.05 mg/mL as the preservative, and also includes disodium hydrogen phosphate heptahydrate, citric acid monohydrate, sodium chloride, and water for injection as inactive ingredients. It is manufactured by Gland Pharma Limited in India and is sold in a 2.5mL bottle. The recommended dosage is one drop in the affected eye(s) once daily in the evening. It is important to store the solution at 2°C to 25°C (36°F to 77°F) and keep it out of reach of children as the package is not child-resistant.*
FDA Label Image

Bimatoprost-carton-5ml (Bimatoprost Carton 5ml)

Bimatoprost-carton-5ml (Bimatoprost Carton 5ml)
This is a description of Bimatoprost Ophthalmic solution, which comes in a 5mL package and is intended for use in the eyes only. It contains Bimatoprost 0.03% (0.3mg) and is sterile. It is used once a day in the evening, with one drop in the affected eye(s). The usual dosage is provided in the accompanying prescribing information. The package is child-resistant, and the solution should be kept out of reach of children. It is manufactured in India by Alembic Pharmaceuticals and distributed in the US by Bedminster. The pH during its shelf life ranges from 6.8 to 7.8.*
FDA Label Image

Bimatoprost-struc (Bimatoprost Struc)

Bimatoprost-struc (Bimatoprost Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.